Shaanxi Kanghui Pharmaceutical Co., Ltd.

SSE:603139.SS

26.2 (CNY) • At close June 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Revenue 121.353157.089138.877135.048123.862200.732202.931145.505123.792116.37132.119125.292117.73107.661120.927117.41996.75121.62116.01493.28383.155126.417118.75398.72787.523127.45685.29587.82175.046134.57581.21492.28258.986151.56383.05490.96256.266
Cost of Revenue 91.664114.0995.73697.3685.992150.442154.18498.14380.9871.89377.16176.46566.84852.74567.44264.75349.66561.89759.03846.18348.52963.60762.650.51646.02565.58441.79338.44237.17155.63133.82241.00824.91360.8937.68739.47224.23
Gross Profit 29.68942.99943.14137.68837.86950.2948.74847.36242.81244.47754.95848.82750.88254.91653.48652.66547.08459.72256.97647.134.62662.8156.15448.21141.49961.87343.50249.37937.87578.94447.39351.27434.07390.67445.36751.4932.037
Gross Profit Ratio 0.2450.2740.3110.2790.3060.2510.240.3260.3460.3820.4160.390.4320.510.4420.4490.4870.4910.4910.5050.4160.4970.4730.4880.4740.4850.510.5620.5050.5870.5840.5560.5780.5980.5460.5660.569
Reseach & Development Expenses 1.8153.6191.3111.1271.8253.4973.2052.2961.9822.5115.7162.6721.4464.0682.6292.1411.3095.3462.2281.2261.5632.962.3730.7022.1811.5241.4445.6191.4689.1831.655.099015.04905.0830
General & Administrative Expenses 13.676-24.02332.697-7.9314.286-18.26525.669-3.2597.725-15.52119.967-3.5597.907-14.49117.071-1.4496.882-5.1444.8461.4525.136-9.055.7690.2624.983-7.9025.784-2.0065.523-8.886.9030.5364.278-12.4195.9686.6223.939
Selling & Marketing Expenses 31.416-5.73763.01439.68120.62134.84730.38229.78326.67235.4842.3231.71328.66935.4837.12836.62228.81235.42134.93626.25519.86642.36730.45428.75321.78331.74524.73728.99219.1140.84121.627.89317.76348.32220.74429.15216.558
SG&A 45.092-29.7695.71150.79833.34716.58256.05126.52534.39719.95962.28828.15436.57520.98954.19935.17335.69430.27839.78227.70725.00233.31836.22329.01426.76623.84330.52126.98624.63331.9628.50228.4322.04135.90326.71335.77420.496
Other Expenses 10.073146.151-17.2510.038-0.0373.9460.003-0.1850.64928.296-12.50412.5650.1360.0260.024-0.069-0.1281.745-0.333-0.337-0.713-0.532-0.164-0.021-0.0922.039-0.0341.2010.033-0.537-0.0320.2520.0671.5350.4580.0920.053
Operating Expenses 56.979120.0179.77151.88635.20952.75745.80143.91437.02850.76655.543.39138.15747.88147.48848.11137.31850.35942.87634.91926.84951.15639.88439.33429.99240.20932.99638.81225.40452.78828.69238.55722.27756.53527.94237.14720.865
Operating Income -27.29-77.011-21.514-14.1992.661-64.609-8.9182.8728.852-95.8841.5026.3111.41913.3537.7567.04710.584.69816.11612.8669.50314.19717.70311.68513.08925.30112.56314.46712.72530.35818.70713.71110.99333.20616.71414.04810.795
Operating Income Ratio -0.225-0.49-0.155-0.1050.021-0.322-0.0440.020.072-0.8240.0110.050.0970.1240.0640.060.1090.0390.1390.1380.1140.1120.1490.1180.150.1990.1470.1650.170.2260.230.1490.1860.2190.2010.1540.192
Total Other Income Expenses Net 0.031.725-14.8595.906-4.2493.9460.003-0.1850.095-6.787-0.1210.013-0.1560.0260.024-0.069-0.1281.745-0.333-0.337-0.713-0.532-0.164-0.021-0.0922.039-0.0341.2010.0330.045-0.053-0.4840.0671.5350.4580.0960.05
Income Before Tax -27.26-75.286-36.372-8.293-1.589-60.664-8.9142.6888.947-102.6712.3426.32311.26313.387.786.97810.4536.44315.78312.5298.7913.66517.53911.66412.99827.3412.52915.66712.75830.40318.65413.22711.05934.74117.17214.14410.845
Income Before Tax Ratio -0.225-0.479-0.262-0.061-0.013-0.302-0.0440.0180.072-0.8820.0180.050.0960.1240.0640.0590.1080.0530.1360.1340.1060.1080.1480.1180.1490.2150.1470.1780.170.2260.230.1430.1870.2290.2070.1550.193
Income Tax Expense 0.197-11.071-5.6996.3320.894-8.782-1.0922.0410.665-9.7551.3320.3552.110.5241.9521.0412.0761.5222.0562.2031.3062.2882.9642.3592.1873.8532.0352.5412.1013.5692.8322.1011.6594.9922.8832.1661.627
Net Income -17.239-51.337-29.586-9.7881.086-35.38-3.3774.3938.206-92.9161.015.1338.79214.8546.3266.1969.1064.5613.2879.2896.97910.43613.1138.91510.29922.7929.82912.78310.22626.67115.82211.1269.40129.74914.28911.9779.219
Net Income Ratio -0.142-0.327-0.213-0.0720.009-0.176-0.0170.030.066-0.7980.0080.0410.0750.1380.0520.0530.0940.0370.1150.10.0840.0830.110.090.1180.1790.1150.1460.1360.1980.1950.1210.1590.1960.1720.1320.164
EPS -0.17-0.511-0.3-0.0980.011-0.37-0.0340.0440.082-0.930.010.0530.090.150.0630.0610.090.0480.140.0930.070.10.130.0870.10.230.10.130.10.270.160.150.130.40.190.160.12
EPS Diluted -0.17-0.511-0.3-0.0980.011-0.37-0.0340.0440.082-0.930.010.0530.090.150.0630.0610.090.0480.140.0930.070.10.130.0870.10.230.10.130.10.270.160.150.130.40.190.160.12
EBITDA -16.399-65.876-27.061.2256.231-27.8551.28213.68919.375-73.0918.3914.71618.45319.3214.14912.69815.27110.57419.33215.47211.72816.72120.4214.60816.02430.1212.56118.28612.9530.82719.13213.29812.29836.38517.82214.34311.172
EBITDA Ratio -0.135-0.419-0.1950.0090.05-0.1390.0060.0940.157-0.6280.0640.1170.1570.1790.1170.1080.1580.0870.1670.1660.1410.1320.1720.1480.1830.2360.1470.2080.1730.2290.2360.1440.2080.240.2150.1580.199